Good Pharmacovigilance Practice Consultative Committee

This section provides information on the Pharmacovigilance Consultative Committee, which is coordinated by the MHRA Pharmacovigilance Inspectorate.

People in a meetingThe Pharmacovigilance Consultative Committee was established in November 2004 and meets twice yearly (one general and one technical meeting).

The terms of reference of the meeting are to advise and provide information to representatives of trade associations and other government departments on to aspects of Good Pharmacovigilance Practice (GPvP) and GPvP inspections.
Terms of ReferencePDF file (opens in new window) (10Kb) (updated November 2007)

Composition of the group includes representatives from the following trade associations:

  • Association of British Pharmaceutical Industry (ABPI)
  • British Association of Research Quality Assurance (BARQA)
  • British Generic Manufacturers Association (BGMA)
  • The Bioindustry Association (BIA)
  • Ethical Medicines Industry Group (EMIG)
  • Herbal Forum
  • The Proprietary Association of Great Britain (PAGB)
  • Pharmaceutical Information and Pharmacovigilance Association (PIPA)
  • The Organisation for Professionals in Regulatory Affairs (TOPRA)

The technical meeting objectives are to provide a forum for discussion on all technical aspects of GPvP and to advise members on the interpretation of the principles of GPvP by the MHRA Inspectors.  Please also refer to our Frequently Asked Questions section for additional information on GPvP.

Minutes of the meetings are published on the MHRA website.

Meeting minutes 6 December 2011PDF file (opens in new window) (37Kb) | Questions for the Committee Meeting in DecemberPDF file (opens in new window) (20Kb)
Meeting minutes 14 June 2011PDF file (opens in new window) (28Kb) | Questions for the Committee Meeting in JunePDF file (opens in new window) (35Kb)
Meeting minutes 7 December 2010PDF file (opens in new window) (36Kb) | Questions for the Committee Meeting in DecemberPDF file (opens in new window) (62Kb)
Meeting minutes 20 May 2010PDF file (opens in new window) (22Kb) | Questions for the Committee Meeting in MayPDF file (opens in new window) (28Kb)
Meeting minutes 5 November 2009PDF file (opens in new window) (45Kb)|Questions for the Committee Meeting in NovemberPDF file (opens in new window) (79Kb)
Meeting minutes 29 May 2009PDF file (opens in new window) (68Kb)|Questions for the Committee Meeting in MayPDF file (opens in new window) (37Kb)
Meeting minutes 20 November 2008PDF file (opens in new window) (38Kb)|Questions for the Committee Meeting in NovemberPDF file (opens in new window) (47Kb)
Meeting minutes 2 May 2008PDF file (opens in new window) (58Kb)|Questions for the Committee Meeting in MayPDF file (opens in new window) (42Kb)
Meeting minutes 2 November 2007PDF file (opens in new window) (33Kb)
Meeting minutes 30 April 2007PDF file (opens in new window) (45Kb)


Contact for further information
For further information on this part of our site, please contact either:

  1. Pharmacovigilance Inspectorate Unit, MHRA, 5 Yellow, 151 Buckingham Palace Road, Victoria, London, SW1W 9SZ, telephone 020 3080 6606 or email info@mhra.gsi.gov.uk
  2. Pharmacovigilance Inspectorate Unit, MHRA, 2 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW, telephone 01707 299130, fax 01707 376649 or email info@mhra.gsi.gov.uk


Page last modified: 08 December 2011